Currently, out of the existing stock ratings of Alex Arfaei - 75 which are a Buy (48.7%), 59 which are a Hold (38.31%), 20 which are a Sell (12.99%)

Alex Arfaei

Work Performance Price Targets & Ratings Chart

Analyst Alex Arfaei was covering the Healthcare sector with 295 price targets and ratings displayed on 8 stocks. Previously, Alex Arfaei worked at BMO.

Alex Arfaei's average stock forecast success ratio is 95.44% with an average time for price targets to be met of 587.63 days.

Most recent stock forecast was given on ZTS, Zoetis at 09-May-2019.

Wall Street Analyst Alex Arfaei

Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for ABBV (ABBVIE) at 11/5/2018. The price target of $71 was fulfilled within 4 days with a profit of $4.23 (6.34%) receiving and performance score of 15.84.

Average potential price target upside

ABBV AbbVie BMY BristolMyers Squibb Company LLY Eli Lilly and Company MRK Merck . PFE Pfizer AZN AstraZeneca PLC KIN ZTS Zoetis

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

177

$27.94 (18.74%)

167

1 days ago

10/14 (71.43%)

$17.75 (15.37%)

122

Buy

170

$20.94 (14.05%)

163

2 months 2 days ago

33/34 (97.06%)

$24.97 (28.96%)

433

Buy

182

$32.94 (22.10%)

181

2 months 19 days ago

6/15 (40%)

$28.98 (32.96%)

467

Buy

155

5 months 25 days ago

1/1 (100%)

$21 (15.67%)

90

Buy

172

$22.94 (15.39%)

166

6 months 29 days ago

23/24 (95.83%)

$22.65 (31.91%)

519

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Alex Arfaei?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart